Abstract
Numerous human diseases are associated with the chronic expression of misfolded and aggregation-prone proteins. The expansion of polyglutamine residues in unrelated proteins is associated with the early onset of neurodegenerative disease. To understand how the presence of misfolded proteins leads to cellular dysfunction, we employed Caenorhabditis elegans polyglutamine aggregation models. Here, we find that polyglutamine expansions disrupted the global balance of protein folding quality control, resulting in the loss of function of diverse metastable proteins with destabilizing temperature-sensitive mutations. In turn, these proteins, although innocuous under normal physiological conditions, enhanced the aggregation of polyglutamine proteins. Thus, weak folding mutations throughout the genome can function as modifiers of polyglutamine phenotypes and toxicity.
References
33
Referenced
541
10.1016/S0092-8674(00)80513-9
10.1126/science.277.5334.1990
10.1126/science.1079469
10.1038/nature02392
- J. F. Gusella, M. E. MacDonald, Nat. Rev. Neurosci.1, 109 (2000). / Nat. Rev. Neurosci. (2000)
10.1083/jcb.143.6.1457
10.1093/hmg/9.14.2197
10.1073/pnas.140202897
10.1038/ncb863
10.1097/00005072-199702000-00002
10.1038/502
10.1126/science.292.5521.1552
10.1038/sj.emboj.7600426
10.1002/ana.410390317
10.1016/S0014-5793(98)01242-3
10.1038/24550
10.1038/342451a0
10.1172/JCI119302
10.1074/jbc.M309514200
10.1073/pnas.152161099
10.1073/pnas.0307697101
- H. R. Brignull S. Tang R. I. Morimoto in preparation.
10.1016/0022-2836(91)90184-8
- Gidalevitz et al. unpublished data.
10.1073/pnas.94.19.10438
- Materials and methods are available as supporting material on Science Online.
10.1093/genetics/146.2.553
10.1016/S0092-8674(85)80031-3
10.1101/gad.12.24.3788
10.1038/35057149
10.1073/pnas.0308679101
10.1016/S0021-9258(18)45598-6
- T.G. was supported by NIH Training Grant T32 HL076139 and by an Individual NRSA F32 GM075583-01; A.B.-Z. was supported by an EMBO Long-Term Fellowship the Parkinson Foundation and the Hereditary Disease Foundation; and H.R.B. was supported by National Institute of General Medical Sciences (NIGMS) Molecular Biology of Disease Training Grant T32 GM08061. R.I.M. was supported by grants from the NIH (NIGMS National Institute of Neurological Disorders and Stroke and National Institute on Aging) the Huntington Disease Society of America Coalition for the Cure the ALS Association and the Daniel F. and Ada L. Rice Foundation. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center which is funded by the NIH National Center for Research Resources (NCRR). We thank J. West and members of the Morimoto laboratory for their discussion and comments on the manuscript and F. Moore for reagents.
Dates
Type | When |
---|---|
Created | 19 years, 6 months ago (Feb. 9, 2006, 8:44 p.m.) |
Deposited | 1 year, 7 months ago (Jan. 9, 2024, 9:08 p.m.) |
Indexed | 3 weeks, 3 days ago (Aug. 3, 2025, 12:26 a.m.) |
Issued | 19 years, 5 months ago (March 10, 2006) |
Published | 19 years, 5 months ago (March 10, 2006) |
Published Print | 19 years, 5 months ago (March 10, 2006) |
@article{Gidalevitz_2006, title={Progressive Disruption of Cellular Protein Folding in Models of Polyglutamine Diseases}, volume={311}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.1124514}, DOI={10.1126/science.1124514}, number={5766}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Gidalevitz, Tali and Ben-Zvi, Anat and Ho, Kim H. and Brignull, Heather R. and Morimoto, Richard I.}, year={2006}, month=mar, pages={1471–1474} }